Career history of Caryn McDowell
Former positions of Caryn McDowell
| Companies | Position | Start | End |
|---|---|---|---|
| QUINCE THERAPEUTICS, INC. | Chief Administrative Officer | 2020-05-10 | 2022-07-07 |
| General Counsel | 2020-05-10 | 2022-07-07 | |
| Corporate Secretary | 2020-05-10 | 2022-07-07 | |
| CYTOKINETICS, INCORPORATED | Compliance Officer | 2016-05-17 | 2018-04-30 |
| General Counsel | 2015-04-30 | 2018-04-30 | |
| INTERMUNE INC | Corporate Officer/Principal | 2013-12-31 | 2015-01-31 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | General Counsel | 2013-05-31 | 2013-11-30 |
| AFFYMAX, INC. | General Counsel | 2011-12-31 | 2012-12-31 |
| US Department of Health & Human Services (DC) | Corporate Officer/Principal | 2000-12-31 | 2003-12-31 |
| REVANCE THERAPEUTICS, INC. | General Counsel | 2018-04-30 | - |
| Corporate Secretary | 2018-04-30 | - | |
| State of Massachusetts | Corporate Officer/Principal | - | - |
Training of Caryn McDowell
| University of Michigan | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Statistics
International
| United States | 11 |
Operational
| General Counsel | 5 |
| Corporate Officer/Principal | 3 |
| Corporate Secretary | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Government | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| AFFYMAX, INC. | Health Technology |
| REVANCE THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
| US Department of Health & Human Services (DC) | Government |
| State of Massachusetts | Government |
- Stock Market
- Insiders
- Caryn McDowell
- Experience
